PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D826F01F1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $29,137
Award facts
- Contract value 100% obligated
- $29,137.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $29,137.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 17, 2025, with an ultimate completion date of October 20, 2025. This non-set-aside award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contractor, headquartered in Conshohocken, Pennsylvania, will perform work at its Corporate Office location. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a comprehensive range of medical commodities to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard.
Under this delivery order, AmerisourceBergen will provide pharmaceutical products and medical supplies in support of military healthcare operations. The company's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. All of AmerisourceBergen's reviewed contract awards have been competitively awarded with firm fixed-price structures, reflecting the company's ability to meet federal procurement standards. The DLA is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among several key contractors serving the Defense Department's global pharmaceutical support requirements.
Quick answers
Who was awarded contract SPE2D826F01F1?
SPE2D826F01F1 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on October 17, 2025.
How much is contract SPE2D826F01F1 worth?
The government has obligated $29,137 on SPE2D826F01F1.
Is contract SPE2D826F01F1 an order under another contract?
Yes. SPE2D826F01F1 is a delivery order under SPE2DX22D0060, an indefinite delivery contract.
Was contract SPE2D826F01F1 competed?
The extent of competition for SPE2D826F01F1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award